glp 1 increase heart rate Why Does GLP-1 Rate? Mechanisms and Management GLP-1 Receptor Agonists in Heart

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Ozempic-era science keeps getting weirder

Experts say high demand for the drugs could force officials to make a decision on insurance coverage.

Originally developed for diabetes management, these medications have been found to promote significant weight loss, making them a popular choice for

Robert Kushner, who helped bring them to market, breaks down how they actually work, who benefits most, and why they're a long-term commitment rather than a quick fix.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, antioxidant, and neuroprotective propertiesthat position them as transformative candidates ...